Answer
Xultophy is indicated to improve glycaemic control in adults with insufficiently controlled type 2 diabetes mellitus, as an adjunct to diet and exercise and in addition to other oral diabetes medicines.
Sources for this answer
- Xultophy 100 units/mL + 3.6 mg/mL solution for injectionNovo Nordisk Limited · emc · SmPC §4.1 Therapeutic Indications · Version 6Document updated
Sources checked